Show simple item record

RESULTS FROM THE BARRETT'S OESOPHAGUS TRIAL 3 (BEST3): A RANDOMISED CONTROLLED TRIAL COMPARING THE CYTOSPONGE (TM)-FF3 TEST WITH USUAL CARE TO IDENTIFY OESOPHAGEAL PRE-CANCER IN PRIMARY CARE PATIENTS WITH CHRONIC GASTROESOPHAGEAL REFLUX

dc.contributor.authorFitzgerald, RC
dc.contributor.authorDi Pietro, M
dc.contributor.authorO'Donovan, M
dc.contributor.authorMuldrew, B
dc.contributor.authorDebiram-Beecham, I
dc.contributor.authorOffman, J
dc.contributor.authorBaseley, L
dc.contributor.authorSmith, SG
dc.contributor.authorAigret, B
dc.contributor.authorWalter, FM
dc.contributor.authorRubin, G
dc.contributor.authorPesola, F
dc.contributor.authorGehrung, M
dc.contributor.authorMaroni, R
dc.contributor.authorSasieni, P
dc.date.accessioned2021-05-28T16:55:18Z
dc.date.available2021-05-28T16:55:18Z
dc.date.issued2020-05
dc.identifier.issn0016-5085
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/72157
dc.description.abstractMeeting Abstract 634 from Crohn's and Colitis Congress, Austin, TX, JAN 23-25, 2020en_US
dc.format.extentS136 - S136
dc.relation.ispartofGASTROENTEROLOGY
dc.titleRESULTS FROM THE BARRETT'S OESOPHAGUS TRIAL 3 (BEST3): A RANDOMISED CONTROLLED TRIAL COMPARING THE CYTOSPONGE (TM)-FF3 TEST WITH USUAL CARE TO IDENTIFY OESOPHAGEAL PRE-CANCER IN PRIMARY CARE PATIENTS WITH CHRONIC GASTROESOPHAGEAL REFLUXen_US
dc.typeConference Proceedingen_US
pubs.author-urlhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000540349500340&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6aen_US
pubs.issue6en_US
pubs.notesNot knownen_US
pubs.publication-statusPublisheden_US
pubs.volume158en_US
rioxxterms.funderDefault funderen_US
rioxxterms.identifier.projectDefault projecten_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record